Secondary Hyperparathyroidism Risk Higher With Furosemide Use
Study reveals 6-fold higher risk of SHPT in patients on furosemide vs hydrochlorothiazide.
Study reveals 6-fold higher risk of SHPT in patients on furosemide vs hydrochlorothiazide.
Enalapril plus folic acid treatment was associated with a 56% reduction in the odds of CKD progression compared with enalapril alone.
In a study, CKD was 16% less likely to develop in low adherers to a DASH dietary pattern.
Prospective study reveals a 1-year surgical intervention rate of 13%.
Serum phosphorus and serum creatinine found to be independent predictors of secondary hyperparathyroidism.